The forecasted sales for Musculo-Skeletal System Medicine in Türkiye between 2024 and 2028 indicate a gradual decline. In 2024, the sales are projected at 372.7 million USD, decreasing to 368.4 million USD in 2025, 364.9 million USD in 2026, 362.1 million USD in 2027, and 359.8 million USD in 2028. The sales data from 2023 stands at 376.5 million USD.
Annual variations from year to year show a consistent downward trend in the market, reflecting a gradual decline each year. This decline can be observed with a reduction percentage of approximately -1.15% from 2023 to 2024, followed by -1.15% from 2024 to 2025, -0.95% from 2025 to 2026, -0.77% from 2026 to 2027, and -0.64% from 2027 to 2028. The Compound Annual Growth Rate (CAGR) over this five-year period is around -0.88%.
Future trends to watch for in the Musculo-Skeletal System Medicine market in Türkiye include the potential impact of new healthcare policies, advances in medical technologies, and changes in demographic factors such as an aging population. Additionally, observe any shifts in market dynamics due to economic conditions, or the emergence of new treatments and drugs that could influence market demand.
